Antenatal Ultrasound Diagnosis of Periventricular Pseudocysts and Postnatal Outcome
NCT ID: NCT05546801
Last Updated: 2023-02-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
46 participants
INTERVENTIONAL
2022-10-12
2022-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prenatal Diagnosis of Antenatal Midgut Volvulus: Specific Ultrasound Features
NCT03362450
Prospective Study of Antenatal Diagnostic Criteria for Digestive Complications of Gastroschisis
NCT04174807
Artificial Intelligence Algorithm for the Screening of Abnormal Fetal Brain Findings at First Trimester Ultrasound Scan
NCT05790473
The Role of Pre-natal Ultrasound in Predicting Outcomes of Fetal Ovarian Cysts
NCT06795685
Effect of Fetal Ovarian Cyst Aspiration to Prevent Torsion
NCT00222066
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Most of studies dealing with periventricular pseudocysts and subsequent neurodevelopment are based on neonatal screening, mostly performed in neonatal units.
Current data in the literature on the postnatal outcome of children screened antenatally are scarce; there are only 5 cohort studies with small numbers on the subject.
The present study aims to improve the information given to the parents during the screening of periventricular pseudocysts in the Pluridisciplinary Center of Prenatal Diagnosis, with retrospective cases screened during the last 5 years in university hospital of Bordeaux.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
questionnaire
Questionnaire on postnatal development
questionnaire
questionnaire on postnatal development
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
questionnaire
questionnaire on postnatal development
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient affiliated with or benefiting from a social security plan.
* Oral informed consent.
Exclusion Criteria
* Blake's pouch cyst
* Choroid plexus cyst
* Periventricular leukomalacia
* Poor understanding of French
* Patient under legal protection.
0 Years
5 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Bordeaux
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU Bordeaux
Bordeaux, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CHUBX 2022/14
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.